Genetic View on the Phenomenon of Combined Diseases in Man

被引:11
|
作者
Puzyrev, V. P. [1 ]
Freidin, M. B. [1 ]
机构
[1] Russian Acad Med Sci, Siberian Branch, Res Inst Med Genet, Moscow 109801, Russia
来源
ACTA NATURAE | 2009年 / 1卷 / 03期
基金
俄罗斯基础研究基金会;
关键词
syntropy; dystropy; syntropic and dystropic genes; genome; phenome; HuGENet; CORONARY-HEART-DISEASE; METHYLENETETRAHYDROFOLATE REDUCTASE GENE; FACTOR-ALPHA GENE; ISCHEMIC-STROKE; RISK-FACTORS; IL6; GENE; POLYMORPHISM; METAANALYSIS; SUSCEPTIBILITY; ASSOCIATION;
D O I
10.32607/20758251-2009-1-3-52-57
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In clinical medicine, the phenomenon of polypathy, as a particular object of investigation, was first put forth by French clinicians at the end of the 19th century through the "arthritismus" doctrine. In the first half of the 20th century, German paediatricians singled out "syntropias," which are combinations of diseases with common pathophysiological mechanisms, and "dystropias," which are diseases that rarely co-occur in one individual. In the present paper, syntropy/dystropy is defined as a natural generic nonrandom phenomenon with an evolutionary-genetic basis. The genes involved in the development of syntropy are called "syntropic genes," whereas the genes that co-participate in pathophysiological mechanisms and prevent the co-occurrence of particular phenotypes are called "dystropic genes." Prospects for studying the genetic basis of this phenomenon are highlighted. The publicly available database HuGENet can be used in order to identify syntropic genes, as will be shown as examples in an analysis of cardiovascular diseases.
引用
收藏
页码:52 / 57
页数:6
相关论文
共 50 条